Dalacin C 150 mg clindamicina

Dalacin C is a widely recognized brand for the antibiotic clindamycin, used to treat various bacterial infections. The brand was originally developed by Upjohn, an American pharmaceutical company founded in 1886. Following a series of mergers and acquisitions, including the merger with Pharmacia and the subsequent acquisition by Pfizer, the brand became part of the Pfizer portfolio.

Today, Dalacin C is manufactured in multiple high-standard pharmaceutical facilities worldwide to serve global markets. It is owned by Pfizer Inc., one of the world's largest premier biopharmaceutical companies headquartered in New York. Pfizer operates as a global entity with diverse manufacturing and distribution subsidiaries in almost every country, ensuring the availability of essential medicines like Dalacin C across Europe, North America, and beyond.